AI startup 10x Science secures $4.8M seed funding

AI's potential in drug discovery is rapidly expanding, but a bottleneck exists in characterizing the numerous drug candidates generated. 10x Science, a new startup, aims to solve this by using AI agents to interpret complex mass spectrometry data, a crucial step for drug development and regulatory compliance. The company announced a $4.8 million seed round led by Initialized Capital to further refine its platform and hire engineers. Their AI model, trained on spectrometry data, assists researchers by automating data analysis and identifying molecular structures, potentially accelerating the drug development pipeline.